Glutamine and asparagine activate mTORC1 independently of Rag GTPases

Delong Meng, Qianmei Yang, Huanyu Wang, +4

Journal of Biological Chemistry

MitophagyAmino AcidsImmunologyPharmacotherapyHypersensitivity +16

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

Gang Shi, Qianmei Yang, Yujing Zhang, +21

Molecular Therapy

IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis

Junfeng Zhang, Yi Lin, Chunlei Li, +18

The Journal of Immunology

Immune RegulationImmunologyDermatologyPsoriatic ArthritisImmune Dysregulation +16

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

Qianmei Yang, Gang Shi, Xiaolei Chen, +20

Theranostics

A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity

Hongwei Tian, Gang Shi, Qin Wang, +11

Signal Transduction and Targeted Therapy

ArfGAP1 inhibits mTORC1 lysosomal localization and activation

Delong Meng, Qianmei Yang, Chase H. Melick, +7

The EMBO Journal

Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins

Chunlei Li, Lei Dai, Junfeng Zhang, +16

Journal of Cellular and Molecular Medicine

A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b

Huiling Wang, Yiming Li, Gang Shi, +15

Molecular Therapy — Oncolytics

SNAT7 regulates mTORC1 via macropinocytosis

Delong Meng, Qianmei Yang, Mi‐Hyeon Jeong, +11

Proceedings of the National Academy of Sciences

<scp>DDA</scp>1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle

Lin Cheng, Qianmei Yang, Can Li, +13

Journal of Cellular and Molecular Medicine